Abstract
Despite significant advances in prevention and management, graft versus host disease (GVHD) is still a leading complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Although skin, gut, liver, thymus, and lung are GVHD targets, neurological complications (NC) have also been reported following allo-HSCT. We demonstrate that the central nervous system (CNS) can be a direct target of alloreactive T cells following allo-HSCT in mice. We found significant infiltration of the CNS with donor T lymphocytes and cell death of neurons and neuroglia in allo-HSCT recipients with GVHD. We also found that allo-HSCT recipients with GVHD had deficits in spatial learning/memory and demonstrated increased anxious behavior. These findings highlight CNS sensitivity to damage caused by alloreactive donor T cells and represent the first characterization of target cell subsets and NC during GVHD. Therefore, these clinically relevant studies offer a novel and rational explanation for the well-described neurological symptoms observed after allo-HSCT. © 2013 by The American Society of Hematology.
Cite
CITATION STYLE
Hartrampf, S., Dudakov, J. A., Johnson, L. K., Smith, O. M., Tsai, J., Singer, N. V., … Van Den Brink, M. R. M. (2013). The central nervous system is a target of acute graft versus host disease in mice. Blood, 121(10), 1906–1910. https://doi.org/10.1182/blood-2012-09-456590
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.